| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 411.65B | 408.89B | 384.82B | 344.61B | 288.21B | 267.75B |
| Gross Profit | 152.76B | 139.55B | 123.17B | 111.51B | 96.22B | 87.42B |
| EBITDA | 107.53B | 103.87B | 74.69B | 68.20B | 56.36B | 50.21B |
| Net Income | 23.47B | 20.30B | 29.19B | 20.13B | 18.47B | 19.09B |
Balance Sheet | ||||||
| Total Assets | 571.19B | 548.95B | 557.41B | 501.54B | 469.98B | 424.93B |
| Cash, Cash Equivalents and Short-Term Investments | 65.85B | 62.95B | 54.01B | 50.47B | 45.73B | 62.23B |
| Total Debt | 112.17B | 93.47B | 101.19B | 100.06B | 58.68B | 51.35B |
| Total Liabilities | 218.45B | 210.44B | 223.99B | 205.77B | 192.12B | 167.09B |
| Stockholders Equity | 349.91B | 336.03B | 331.26B | 293.98B | 271.91B | 253.09B |
Cash Flow | ||||||
| Free Cash Flow | 25.03B | 37.90B | 21.92B | -4.75B | -26.36B | 25.95B |
| Operating Cash Flow | 58.77B | 87.76B | 50.87B | 48.63B | 28.74B | 40.00B |
| Investing Cash Flow | -38.33B | -52.07B | -35.80B | -46.27B | -39.93B | -10.77B |
| Financing Cash Flow | -18.05B | -25.45B | -15.34B | 1.10B | -7.93B | -18.85B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥127.84B | 21.86 | 12.54% | 1.84% | 13.86% | 51.05% | |
72 Outperform | ¥865.55B | 16.97 | 6.61% | 1.58% | 5.02% | -27.41% | |
72 Outperform | ¥75.23B | 11.99 | 16.37% | 2.79% | 31.48% | 16.11% | |
69 Neutral | ¥219.97B | 10.37 | 9.02% | 3.11% | 1.25% | -3.97% | |
68 Neutral | ¥671.35B | 23.01 | ― | 1.43% | 7.87% | 38.32% | |
66 Neutral | ¥172.41B | -49.70 | ― | 2.41% | 2.47% | 1.47% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |